References
1. Hegade VS, Sheridan MB, Huggett MT. Diagnosis and management of
IgG4-related disease. Frontline Gastroenterol. 2019;10:275–83.
2. De Buy Wenniger LJM, Culver EL, Beuers U. Exposure to occupational
antigens might predispose to IgG4-related disease. Hepatol Baltim Md.
2014;60:1453–4.
3. Huggett MT, Culver EL, Kumar M, et al. Type 1 autoimmune pancreatitis
and IgG4-related sclerosing cholangitis is associated with
extrapancreatic organ failure, malignancy, and mortality in a
prospective UK cohort. Am J Gastroenterol. 2014;109:1675–83.
4. Stone JH, Brito-Zerón P, Bosch X, et al. Diagnostic Approach to the
Complexity of IgG4-Related Disease. Mayo Clin Proc. 2015;90:927–39.
5. Akiyama M, Kaneko Y and Takeuchi T. Characteristics and prognosis of
IgG4-related periaortitis/periarteritis: A systematic literature review.
Autoimmun Rev . 2019 Sep;18(9):102354.
6. Shovman O, Shoenfeld Y. IgG4-Related Disease and Eosinophilic
Granulomatosis with Polyangiitis: Similarity or Coexistence? Isr Med
Assoc J . 2019 Feb;21(2):122-123.
7. Takahashi N, Fletcher JG, Fidler JL, et al. Dual-phase CT of
autoimmune pancreatitis: a multireader study. AJR Am J Roentgenol.
2008;190:280–6.
8. Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis:
differences between the focal and diffuse forms in 87 patients. Am J
Gastroenterol. 2009;104:2288–94.
9. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the
pathology of IgG4-related disease. Mod Pathol Off J U S Can Acad Pathol
Inc. 2012;25:1181–92.
10. Haba S, Yamao K, Bhatia V, et al. Diagnostic ability and factors
affecting accuracy of endoscopic ultrasound-guided fine needle
aspiration for pancreatic solid lesions: Japanese large single center
experience. J Gastroenterol. 2013;48:973–81.
11. Mizuno N, Bhatia V, Hosoda W, et al. Histological diagnosis of
autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison
study with EUS-FNA. J Gastroenterol. 2009;44:742–50.
12. Kwon S, Kim MH, Choi EK. The diagnostic criteria for autoimmune
chronic pancreatitis: it is time to make a consensus. Pancreas.
2007;34:279–86.
13. Sumimoto K, Uchida K, Mitsuyama T, et al. A proposal of a diagnostic
algorithm with validation of International Consensus Diagnostic Criteria
for autoimmune pancreatitis in a Japanese cohort. Pancreatol Off J Int
Assoc Pancreatol IAP Al. 2013;13:230–7.
14. Deshpande V, Gupta R, Sainani N, et al. Subclassification of
autoimmune pancreatitis: a histologic classification with clinical
significance. Am J Surg Pathol. 2011;35:26–35.
15. Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients
with autoimmune pancreatitis. Am J Gastroenterol. 2013;108:610–7.
16. Ikeura T, Miyoshi H, Uchida K, et al. Relationship between
autoimmune pancreatitis and pancreatic cancer: a single-center
experience. Pancreatol Off J Int Assoc Pancreatol IAP Al.
2014;14:373–9.
17. Asano J, Watanabe T, Oguchi T, et al. Association Between
Immunoglobulin G4-related Disease and Malignancy within 12 Years after
Diagnosis: An Analysis after Longterm Followup. J Rheumatol.
2015;42:2135–42.
18. Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of
autoimmune pancreatitis: a multicentre, international analysis. Gut.
2013;62:1771–6.
19. Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in
IgG4-related disease. Mod Rheumatol. 2012;22:414–8.
20. Hirano K, Tada M, Sasahira N, et al. Incidence of malignancies in
patients with IgG4-related disease. Intern Med Tokyo Jpn.
2014;53:171–6.
21. Hart PA, Law RJ, Dierkhising RA, Smyrk TC, Takahashi N, Chari ST.
Risk of cancer in autoimmune pancreatitis: a case-control study and
review of the literature. Pancreas. 2014 ;43:417–21.
22. Dite P, Novotny I, Dvorackova J, et al. Pancreatic Solid Focal
Lesions: Differential Diagnosis between Autoimmune Pancreatitis and
Pancreatic Cancer. Dig Dis Basel Switz. 2019;37:416–21.
23. Sah RP, Chari ST. Serologic issues in IgG4-related systemic disease
and autoimmune pancreatitis. Curr Opin Rheumatol. 2011;23:108–13.
24. Detlefsen S, De Vos JD, Tanassi JT, et al. Value of anti-plasminogen
binding peptide, anti-carbonic anhydrase II, immunoglobulin G4, and
other serological markers for the differentiation of autoimmune
pancreatitis and pancreatic cancer. Medicine (Baltimore).
2018;97:e11641.
25. Chang MC, Liang PC, Jan S, et al. Increase diagnostic accuracy in
differentiating focal type autoimmune pancreatitis from pancreatic
cancer with combined serum IgG4 and CA19-9 levels. Pancreatol Off J Int
Assoc Pancreatol IAP Al. 2014;14:366–72.
Figure 1. I.V. contrast enhanced T1 FS axial MRI at the level
of the pancreas, showing a hypointense mass (curser) in the pancreatic
tail, 12 months (A) and 18 months (B) after the Whipple procedure, which
increased in size.